CELC Celcuity Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
12:58
Aug 17
Aug 17
Reports largest aggregate Q2 fund holdings
"Reports largest aggregate Q2 2026 holdings across 95 specialist funds based on 13F filings, no directional view."
MED
12:52
Aug 17
Aug 17
Reports most closed positions across funds
"Reports most closed positions across specialist funds in Q2 2026 excluding M&A take-outs, no directional view."
MED
12:31
Aug 17
Aug 17
Notes large aggregate Q2 fund holdings
Notes the stock is among the largest aggregate Q2 holdings across 93 funds based on 13F filings.
MED
17:25
Aug 10
Aug 10
Highlights past successful biotech valuation calls.
Author lists numerous biotech and pharma tickers as past successful valuation calls, offering no current directional view.
LOW
02:58
Jul 27
Jul 27
Leerink Partners raises its price target for Celcuity to 148 dollars.
Leerink Partners raises its price target for Celcuity to 148 dollars, reflecting an optimistic outlook on the stock.
14:02
Jul 17
Jul 17
The author warns of a stealth correction with many former leaders down over 40%.
The author warns of a stealth correction with many former leaders down over 40%, but advises tightening stops rather than indiscriminate exits, maintaining a cautious watch on listed names.
14:13
Jul 15
Jul 15
Author likes COGT and CELC a lot in reply to a direct question about COGT.
Author likes COGT and CELC a lot in reply to a direct question about COGT, indicating a bullish view on both tickers.
17:51
Jul 14
Jul 14
The author is compiling a list of follower-requested stocks for future review without.
The author is compiling a list of follower-requested stocks for future review without expressing any current positions or trade ideas.
LOW
07:31
Jul 05
Jul 05
The author lists 23 stocks he plans to review after receiving suggestions from followers.
The author lists 23 stocks he plans to review after receiving suggestions from followers, with no current position or directional view expressed.
LOW
00:55
Jun 21
Jun 21
The tweet maps biotech M&A timing and independent name catalysts since the XBI bottom.
The tweet maps biotech M&A timing and independent name catalysts since the XBI bottom, but it is a factual research summary without explicit author positions or forward calls.
LOW
17:44
May 07
May 07
The author lays out a concentrated long biotech portfolio on a down XBI day.
The author lays out a concentrated long biotech portfolio on a down XBI day, highlighting ABVX as a major position and listing other names under consideration, reflecting a bullish sector outlook despite short-term losses.
HIGH
About CELC Analyst Coverage
Buzzberg tracks CELC (Celcuity Inc.) across 4 sources. 0 bullish vs 0 bearish calls from 4 analysts. Sentiment: evenly split. 11 total trade ideas tracked. Latest voices: seedy19tron, FirstSquawk, Mark Minervini.